CORT

Corcept Therapeutics Incorporated

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$42.49

Market Cap

$4.52B

Beta

0.25

P/E

52.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+12.79%

EPS Growth (YoY)-33.87%

Revenue CAGR 3Y+23.74%

P/E Ratio52.4

PEG Ratio—

FCF Yield+3.14%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CORT.